News

Read about the latest developments in RECOVER

RECOVER Social Science study: people could better protect themselves from COVID-19 in their own home

In March 2021, the RECOVER Social Science team has published a paper on the experiences and needs of persons living with a household member infected with SARS-CoV-2. Households are important sites for transmission of SARS-CoV-2 and preventive measures are recommended. This study aimed to investigate the impact of living with a person infected with SARS-CoV-2, understand how household members implemented infection control recommendations in their home, and identify the information and support needs of household members.

Read More »

The third point prevalence audit survey captures information on care delivery and patient management during COVID-19 pandemic

The delivery of primary health care, especially for patients with symptoms of a respiratory tract infection, has been highly affected by the COVID-19 pandemic. Preventive measures, frequently changing advice and guidelines, implementation of diagnostic testing by general practices and later by routine community surveillance, changed consultation behaviours because of fear for COVID-19 and not wanting to unnecessarily use health care resources urged for constant adaptations in care delivery.

Read More »

REMAP-CAP published results on tocilizumab and sarilumab in COVID-19 patients

On February 25, the REMAP-CAP paper: “Interleukin-6 Receptor Antagonists in Critically Ill Patients with COVID-19” was published in the New England Journal of Medicine. It shows the results of the use of tocilizumab and sarilumab in patients with severe COVID-19. Adult patients with COVID-19 who received organ support in the intensive care unit within 24 hours, were randomly assigned to receive tocilizumab, sarilumab, or standard care. The publication shows that in critically ill patients with COVID-19 receiving organ support in ICUs, treatment with the interleukin-6 receptor antagonists tocilizumab and sarilumab improved outcomes, including survival.

Read More »

RECOVER Social Science team will present at SW SAPC conference 2021

On Thursday 18 March 2021, the RECOVER Social Science team will present the results of their qualitative study at the SW SAPC on-line conference 2021. The study focuses on patients and healthcare professionals’ (HCPs) experiences of receiving and delivering care during the COVID-19 pandemic in 8 European countries.

Read More »

PRESS RELEASE: ECRAID-Base launches European Clinical Research Alliance

Following the signing of the Grant Agreement by the European Commission (EC), ECRAID-Base has secured funding of 30 million euros and will commence March 1st 2021. ECRAID-Base is the core set of activities for ECRAID (the European Clinical Research Alliance for Infectious Diseases), which aspires to become the first of its kind, pan-European clinical research network for infectious diseases in Europe. Over the five-year duration of ECRAID-Base, ECRAID will evolve into a self-sustaining, not-for-profit organisation conducting clinical research for both public and private sponsors.

Read More »

REMAP-CAP Launched its Second Video

REMAP-CAP, an Adaptive Platform Trial for Community-Acquired Pneumonia, launched its second in a series of videos. The video shows the uniqueness, smart, and easy-to-handle design of this trial. As an adaptive platform, REMAP-CAP is designed to adapt in the event of a pandemic, increasing the likelihood of patients receiving an effective treatment.

Read More »